Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Shan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3340-3768; OpenAlex author ID A5100325416. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 4 papers

Papers 10

  1. Vitamin D Binding Protein, a Ligand of Integrin beta 1, Motivates Both Tumor Cells and Schwann Cells to Promote Perineural Invasion in Pancreatic Ductal Adenoc… Co-author DOI 10.1002/advs.202511726↗
  2. Vitamin K-dependent gamma-carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosin… Co-author DOI 10.1002/ctm2.70191↗
  3. Targeting stiff stroma by neutralizing LOX-mediated matrix crosslinking in pancreatic cancer. Co-author DOI 10.1016/j.apsb.2025.03.010↗
  4. Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer. Co-author DOI 10.1016/j.tins.2024.11.008↗
  5. Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10142-023-01020-4↗
  6. The genomic, transcriptomic, and immunological profiles of perineural invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11427-022-2146-5↗
  7. Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic … Co-author DOI 10.1007/s13402-023-00824-7↗
  8. Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2022.104050↗
  9. DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway. Co-author DOI 10.2147/ott.s229055↗
  10. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling. Co-author DOI 10.1038/s41598-019-44048-y↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shu‐Heng Jiang · 8 shared papers, 2022–2025 · strength 1.71
  2. Luju Jiang · 3 shared papers, 2025 · strength 0.84
  3. Shuqi Cai · 3 shared papers, 2025 · strength 0.84
  4. Xiaomei Yang · 4 shared papers, 2023–2025 · strength 0.76
  5. Zhigang Zhang · 4 shared papers, 2022–2025 · strength 0.72
  6. Hong‐Fei Yao · 2 shared papers, 2023–2025 · strength 0.39
  7. Li-Peng Hu · 2 shared papers, 2022–2025 · strength 0.37
  8. Xueli Zhang · 2 shared papers, 2023–2025 · strength 0.37
  9. Qin Yang · 2 shared papers, 2023 · strength 0.34
  10. Yongwei Sun · 2 shared papers, 2022–2023 · strength 0.33
  11. Dejun Liu · 2 shared papers, 2022–2023 · strength 0.33
  12. Dong‐Xue Li · 1 shared paper, 2025 · strength 0.21
  13. Zheng Wu · 1 shared paper, 2025 · strength 0.21
  14. Zong‐Hao Duan · 1 shared paper, 2025 · strength 0.21
  15. Qing Ye · 1 shared paper, 2025 · strength 0.21
  16. Linli Yao · 1 shared paper, 2025 · strength 0.21
  17. Dejun Liu · 1 shared paper, 2025 · strength 0.21
  18. Yu-Heng Zhu · 1 shared paper, 2025 · strength 0.21
  19. Dongxue Li · 1 shared paper, 2025 · strength 0.21
  20. Qing Li · 1 shared paper, 2025 · strength 0.21
  21. Rong Hua · 1 shared paper, 2025 · strength 0.21
  22. Zhongxia Wang · 2 shared papers, 2019–2020 · strength 0.20
  23. Wei Hu · 2 shared papers, 2019–2020 · strength 0.20
  24. Rongkun Li · 1 shared paper, 2023 · strength 0.16
  25. Xu Wang · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.